1887
Rapid communication Open Access
Like 0

Abstract

We analysed the first 84 coronavirus disease (COVID-19) patients hospitalised in an infectious and tropical disease unit in Florence, Italy, over 30 days after the start of the COVID-19 outbreak in Italy. A 12% reduction in the rate of intensive care unit transfer was observed after the implementation of intensity care measures in the regular ward such as increasing the nurse/patient ratio, presence of critical care physicians and using high flow nasal cannulae oxygenation.

Loading

Article metrics loading...

/content/10.2807/1560-7917.ES.2020.25.17.2000556
2020-04-30
2020-10-29
http://instance.metastore.ingenta.com/content/10.2807/1560-7917.ES.2020.25.17.2000556
Loading
Loading full text...

Full text loading...

/deliver/fulltext/eurosurveillance/25/17/eurosurv-25-17-2.html?itemId=/content/10.2807/1560-7917.ES.2020.25.17.2000556&mimeType=html&fmt=ahah

References

  1. Onder G, Rezza G, Brusaferro S. Case-fatality rate and characteristics of patients dying in relation to COVID-19 in Italy. JAMA. 2020;2019:2019-20.  https://doi.org/10.1001/jama.2020.4683  PMID: 32203977 
  2. World Health Organization (WHO). Coronavirus disease 2019 (COVID-19). Situation report – 98. Geneva: WHO; 2020. Available from: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200427-sitrep-98-covid-19.pdf?sfvrsn=90323472_4
  3. Giacomelli A, Pezzati L, Conti F, Bernacchia D, Siano M, Oreni L, et al. Self-reported olfactory and taste disorders in SARS-CoV-2 patients: a cross-sectional study. Clin Infect Dis. 2020; ciaa330: Epub ahead of print.
  4. Lechien JR, Chiesa-Estomba CM, De Siati DR, Horoi M, Le Bon SD, Rodriguez A, et al. Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European study. Eur Arch Otorhinolaryngol. 2020.  https://doi.org/10.1007/s00405-020-05965-1  PMID: 32253535 
  5. Lin L, Lu L, Cao W, Li T. Hypothesis for potential pathogenesis of SARS-CoV-2 infection-a review of immune changes in patients with viral pneumonia. Emerg Microbes Infect. 2020;9(1):727-32.  https://doi.org/10.1080/22221751.2020.1746199  PMID: 32196410 
  6. Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, HLH Across Speciality Collaboration, UK. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033-4.  https://doi.org/10.1016/S0140-6736(20)30628-0  PMID: 32192578 
  7. Guan W-J, Ni Z-Y, Hu Y, Liang W-H, Ou C-Q, He J-X, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020; NEJMoa2002032: Epub ahead of print.  PMID: 32109013 
  8. World Health Organization (WHO). Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected. Interim guidance V 1.2. Geneva: WHO; 13 Mar 2020.Available from: https://www.who.int/publications-detail/clinical-management-of-severe-acute-respiratory-infection-when-novel-coronavirus-(ncov)-infection-is-suspected
  9. Shang L, Zhao J, Hu Y, Du R, Cao B. On the use of corticosteroids for 2019-nCoV pneumonia. Lancet. 2020;395(10225):683-4.  https://doi.org/10.1016/S0140-6736(20)30361-5  PMID: 32122468 
/content/10.2807/1560-7917.ES.2020.25.17.2000556
Loading

Data & Media loading...

Comment has been disabled for this content
Submit comment
Close
Comment moderation successfully completed
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error